[1]
R. A. Aladhab, “Association of empagliflozin treatment with changes in the metabolic score for insulin resistance in Iraqi adults with type 2 diabetes: a 6-month prospective cohort study”, Int J Basic Clin Pharmacol, vol. 15, no. 5, pp. 837–843, Aug. 2026.